Want to see MNPR full AI Analyst Report?
Monopar Therapeutics Inc (MNPR) Ownership Overview
18.14% Insiders
6.76% Mutual Funds
0.03% Other Institutional Investors
6.56% ETFs
68.50% Public Companies and
Individual Investors
The ownership structure of Monopar Therapeutics Inc (MNPR) stock is a mix of institutional, retail, and individual investors. Approximately 13.36% of the company’s stock is owned by Institutional Investors, 18.14% is owned by Insiders, and 68.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 29, 2025 | xxxxxxxxxxxxx | $104925 | |
Dec 19, 2025 | xxxxxxxxxxxxx | $343889 | |
Sep 26, 2025 | xxxxxxxxxxxxx | $34994564 | |
Jul 16, 2025 | xxxxxxxxxxxxx | $672000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2024 | xxxxxxxxxxxxx | $17737989 | |
Dec 31, 2024 | xxxxxxxxxxxxx | $1816617 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 667,207 | Institution | 9.96% | 70,657,221 | |
| 661,330 | Insider | 9.87% | 70,034,847 | |
| 323,745 | Institution | 4.83% | 34,284,596 | |
| 272,026 | Insider | 4.06% | 28,807,553 | |
| 244,258 | Institution | 3.65% | 25,866,922 | |
| 212,456 | Institution | 3.17% | 22,499,090 | |
| 162,082 | Insider | 2.42% | 17,164,484 | |
| 157,291 | Institution | 2.35% | 16,657,117 | |
| 55,614 | Insider | 0.83% | 5,889,523 | |
| 47,633 | Institution | 0.71% | 5,044,335 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 212,456 | Institution | 3.17% | 22,499,090 | |
| 47,633 | Institution | 0.71% | 5,044,335 | |
| 41,243 | Institution | 0.62% | 4,367,634 | |
| 34,428 | Institution | 0.51% | 3,645,925 | |
| 27,214 | Institution | 0.41% | 2,881,963 | |
| 26,214 | Institution | 0.39% | 2,776,063 | |
| 19,943 | Institution | 0.30% | 2,111,964 | |
| 12,558 | Institution | 0.19% | 1,329,892 | |
| 5,551 | Institution | 0.08% | 587,851 | |
| 4,906 | Institution | 0.07% | 519,545 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 159,786 | Institution | 2.39% | 14,794,586 | |
| 119,897 | Institution | 1.79% | 13,322,955 | |
| 45,173 | Institution | 0.67% | 4,182,568 | |
| 25,913 | Institution | 0.39% | 2,399,285 | |
| 15,248 | Institution | 0.23% | 1,614,763 | |
| 10,387 | Institution | 0.16% | 1,154,203 | |
| 9,926 | Institution | 0.15% | 1,102,977 | |
| 9,347 | Institution | 0.14% | 1,014,336 | |
| 7,086 | Institution | 0.11% | 768,973 | |
| 5,474 | Institution | 0.08% | 579,697 |
FAQ
Who Owns Monopar Therapeutics Inc (MNPR)?
According to the latest TipRanks data, approximately 0.03% of the company's stock is held by institutional investors, 18.14% is held by insiders, and 68.50% is held by retail investors.
What percentage of Monopar Therapeutics Inc (MNPR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.03% of Monopar Therapeutics Inc (MNPR) stock is held by institutional investors.
What percentage of Monopar Therapeutics Inc (MNPR) stock is held by retail investors?
According to the latest TipRanks data, approximately 68.50% of Monopar Therapeutics Inc (MNPR) stock is held by retail investors.
Who owns the most shares of Monopar Therapeutics Inc (MNPR)?
Peter Kolchinsky owns the most shares of Monopar Therapeutics Inc (MNPR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.